New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 25, 2013
07:59 EDTVPHMConcerns over ViroPharma competition overblown, says Oppenheimer
After meeting with ViroPharma investors, Oppenheimer believes that investors are concerned about potential competition for the company in the prophylactic space. The firm, however, thinks this concern is overblown, given what it sees as under-appreciated hurdles for U.S. approval of competitive products. The firm maintains an Outperform rating on the stock.
News For VPHM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for VPHM

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use